CoChat

Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors

Open access

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; none of the 20 sources its claims cite is checked for support yet.

Abstract

Background and purpose: Depression is common after stroke and is often treated with antidepressant medications (AD). ADs have also been hypothesised to improve stroke recovery, although recent randomised trials were neutral. We investigated the patterns of in-hospital AD initiation after ischaemic stroke and association with clinical and readmission outcomes. Methods: All Medicare fee-for-service beneficiaries aged 65 or older hospitalised for ischaemic stroke in participating Get With The Guidelines-Stroke hospitals between April and December 2014 were eligible for this analysis. Outcome measures included days alive and not in a healthcare institution (home time), all-cause mortality and readmission within 1-year postdischarge. Propensity score (PS)-adjusted logistic regression models were used to evaluate the associations between AD use and each outcome measure. We also compared outcomes in patients prescribed selective serotonin reuptake inhibitors (SSRIs) AD versus those prescribed non-SSRI ADs. Results: Of 21 805 AD naïve patients included in this analysis, 1835 (8.4%) were started on an AD at discharge. Patients started on an AD had higher rates of depression and prior ischaemic stroke, presented with higher admission National Institutes of Health Stroke Scale score and were less likely to be discharged home. Similarly, patients started on an SSRI had lower rates of discharge to home. Adjusting for stroke severity, patients started on an AD had worse all-cause mortality, all-cause readmission, major adverse cardiac events, readmission for depression and decreased home-time. However, AD use was also associated with an increased risk for the sepsis, a falsification endpoint, suggesting the presence of residual confounding. Conclusions: Patients with ischaemic stroke initiated on AD therapy are at increased risk of poor clinical outcomes and readmission even after PS adjustment, suggesting that poststroke depression requiring medication is a poor prognostic sign. Further research is needed to explore the reasons why depression is associated with worse outcome, and whether AD treatment modifies this risk or not.

Overview

CoChat Summary

TL;DR

In this national retrospective registry analysis of Medicare fee-for-service patients aged 65+ hospitalized for ischaemic stroke, 8.4% of 21,805 antidepressant-naïve patients were newly started on an antidepressant at discharge. Those started on antidepressants had worse 1-year outcomes after adjustment, including lower home time, higher mortality, and more readmissions, though the sepsis falsification endpoint suggested residual confounding.

Key findings

  • Among 21,805 antidepressant-naïve patients from 999 hospitals, 1,835 (8.4%) were started on an antidepressant at discharge.
  • After overlap-weight adjustment, antidepressant initiation was associated with shorter home time and worse 1-year outcomes, including all-cause mortality, all-cause readmission, MACE, and readmission for depression or non-cardiovascular reasons.
  • No difference was observed in stroke/TIA or cardiovascular readmissions between the antidepressant and no-antidepressant groups after adjustment.
  • The association with readmission for sepsis, used as a falsification endpoint, persisted after adjustment, suggesting residual confounding.

Methods

  • Retrospective analysis of the Get With The Guidelines-Stroke Registry linked to Centers for Medicare & Medicaid Services data.
  • Included Medicare fee-for-service beneficiaries aged 65 or older with a final clinical diagnosis of ischaemic stroke, discharged April–December 2014, excluding hospice/AMA discharge, in-hospital death, missing discharge antidepressant documentation, fee-for-service ineligibility, and contraindications to antidepressants.
  • Used propensity score overlap weighting and regression models to compare antidepressant vs no antidepressant, and SSRI vs non-SSRI, on 1-year home time, mortality, readmission, and related endpoints.

Limitations

  • The paper states this was a retrospective analysis of a national registry during a finite time period, which may limit generalisability.
  • The paper states that indication, dose, duration, and adherence to antidepressant/SSRI treatment were not available, and direct information on poststroke depression rates was also lacking.
  • Evident from the text: residual confounding likely remains, because the antidepressant group also had increased sepsis readmission, the falsification endpoint.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/svn-2020-000691

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Inclusion/exclusion criteria. AD, antidepressant; FFS, fee for service; GWTG, get with the guidelines.
Figure 1 Inclusion/exclusion criteria. AD, antidepressant; FFS, fee for service; GWTG, get with the guidelines.CC BY-NC · PubMed Central
Figure 2 Cumulative incidence plots for 1-year follow-up outcomes in AD naïve patients for (A) 1-year mortality; (B) 1-year MACE and (C) 1-year all-cause readmission. AD, antidepressant; MACE, major adverse cardiac events.
Figure 2 Cumulative incidence plots for 1-year follow-up outcomes in AD naïve patients for (A) 1-year mortality; (B) 1-year MACE and (C) 1-year all-cause readmission. AD, antidepressant; MACE, major adverse cardiac events.CC BY-NC · PubMed Central
Figure 3 Cumulative incidence plots for 1-year follow-up readmission outcomes in AD naïve patients for (A) cardiovascular readmission; (B) non-cardiovascular readmission; (C) IS/TIA readmission and (D) depression readmission. AD, antidepressant; CV, cardiovascular; IS, ischaemic attack; TIA, transient ischaemic attack.
Figure 3 Cumulative incidence plots for 1-year follow-up readmission outcomes in AD naïve patients for (A) cardiovascular readmission; (B) non-cardiovascular readmission; (C) IS/TIA readmission and (D) depression readmission. AD, antidepressant; CV, cardiovascular; IS, ischaemic attack; TIA, transient ischaemic attack.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 5 Not checked · 39 Own results and interpretations

26 more claims

Create a free account to see all 44 claims and to verify the 20 references still open.

See all claims — free account
  • The quote only partly states this claim. 2
  • It may state two separate claims as one. 6
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Citations

Cites

Show all 32 references

Cited by

See all 10

Metadata

Authors
Etherton, M. R., Shah, S., Haolin, X., Xian, Y., Maisch, L., Hannah, D., Lindholm, B., Lytle, B., Thomas, L., Smith, E. E., Fonarow, G. C., Schwamm, L. H., Bhatt, D. L., Hernandez, A. F., & O'Brien, E. C.
Affiliations
  • Massachusetts General Hospital (US)
  • Duke University (US)
  • Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA
  • American Heart Association (US)
  • University of Calgary (CA)
  • University of California, Los Angeles (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Etherton, Mark R
Venue
Stroke and Vascular Neurology
Publisher
BMJ
Published
2021-02-01
Volume
6
Issue
3
Pages
384-394
ISSN
  • 2059-8688 (ISSN-L)
  • 2059-8696
OpenAlex
W3127367272
Cited by
10
References
33
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • Stroke and Vascular Neurology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
Funders
  • American Heart Association (Get With The Guidelines -- Stroke)
  • Patient-Centered Outcomes Research Institute (CE-1304-7073)
Topics
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
antidepressant treatment, ischemic stroke, post-stroke depression, selective serotonin reuptake inhibitors, hospital readmission, all-cause mortality, stroke recovery, home discharge, residual confounding, sepsis, older adults
MeSH terms
Ischemic Stroke, Aftercare, Aged, Antidepressive Agents, Brain Ischemia, Medicare, Humans, Patient Discharge, United States, Survivors, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors. https://app.cochat.ai/papers/10.1136/svn-2020-000691
The paper
Etherton, M. R., Shah, S., Haolin, X., Xian, Y., Maisch, L., Hannah, D., Lindholm, B., Lytle, B., Thomas, L., Smith, E. E., Fonarow, G. C., Schwamm, L. H., Bhatt, D. L., Hernandez, A. F., & O'Brien, E. C. (2021). Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors. Stroke and Vascular Neurology. https://doi.org/10.1136/svn-2020-000691

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.